IL1B and neoplasm: In line with our NF-κB findings, IHC revealed a largely decreased expression of phosphorylated STAT3 (p-STAT3) in the tumor lesions of anti–IL-1β–treated mice at the age of 14 or 18 weeks (Figure 6, D–F).